![](/images/icons/PDFIcon.png) |
11_Scott_FDA_multiplicity_guidance |
![](/images/icons/PDFIcon.png) |
12_Benda_Multiplicity |
![](/images/icons/PDFIcon.png) |
21_Petavy_Estimand_into_regulatory |
![](/images/icons/PDFIcon.png) |
22_Bretz_ICH_E9_addendum |
![](/images/icons/PDFIcon.png) |
31_Callegari_estimand_pain |
![](/images/icons/PDFIcon.png) |
32_Rufibach_Estimand_MS |
![](/images/icons/PDFIcon.png) |
41_Rantell_biomarkers_ED |
![](/images/icons/PDFIcon.png) |
42_Vonk_Early_Clinical_Statistics_in_Decision_Processes |
![](/images/icons/PDFIcon.png) |
43_Sander_Guettner_Cosentyx_casestudy |
![](/images/icons/PDFIcon.png) |
51_Stone_predictive_biomarkers |
![](/images/icons/PDFIcon.png) |
52_Florance_drug-device_co-development |
![](/images/icons/PDFIcon.png) |
53_Heinzmann_MetMab |
![](/images/icons/PDFIcon.png) |
54_Burger_Biomarker_BigData |
![](/images/icons/PDFIcon.png) |
61_Stalbovskaya_Basket_and_platform_protocols |
![](/images/icons/PDFIcon.png) |
62_Guizzaro_delayted_start_NS |